BD Physioject™ disposable autoinjector

Optimize autoinjection ergonomics and functionality

The BD Physioject™ disposable autoinjector is a disposable autoinjector for pre-filled syringes. Incorporating patient input and rigorous human factors studies, it is designed to fully integrate with the BD Neopak™ 1-mL–long glass pre-fillable syringe or the BD Hypak™ for biotech 1-mL–long glass pre-fillable syringe to ensure optimal system functionality.1

Easy use

Featuring one-button activation of subcutaneous injections and automatic needle protection, the autoinjector enables easy use and safe handling for patients.2

Increased patient confidence

A large window provides a 360-degree view of the drug, giving patients visual confirmation that they have completed their injection.

Customizable dosage

Injection rates can be customized to the patient's drug therapy needs.

Accelerated development

The autoinjector is available under the BD Accelerate program to enable faster time to market.

Infection prevention

Single-use autoinjection helps prevent infection.


Branding options

Various color and design options are available to satisfy branding and other requirements.


Easy assembly

The autoinjector consists of only two components, easing assembly.


Full integration

Fully integrated, the autoinjector optimizes system functionality.


Proven solution

The autoinjector has undergone extensive testing via market research and clinical studies.3–7


Accelerated development

The autoinjector is available for customization in accelerated development, enabling a faster time to market.


Related Products



References
  1. Independent heuristic usability and risk evaluation conducted on prototypes on concept #2 (w/glass syringe) [user studies]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2010.
  2. U.S. Food and Drug Administration. Guidance on the Content and Format of Premarket Notification [510(k)] Submissions for Sharps Containers. Silver Spring, MD: U.S. Food and Drug Administration; 1993.
  3. Assessment of unmet needs for patients with multiple sclerosis and rheumatoid arthritis [patient interviews]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2010.
  4. Assessment of experiences with noninjectors for healthy patients [patient interviews]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2011.
  5. Assessment of experiences with injectors and noninjectors for patients with rheumatoid arthritis and diabetes. Franklin Lakes, NJ: Becton, Dickinson and Company; 2014.
  6. Assessment of experiences with injectors and noninjectors for patients with rheumatoid arthritis and mild cognitive impairment. Franklin Lakes, NJ: Becton, Dickinson and Company; 2015.
  7. Assessment of experiences with injectors and noninjectors for patients with rheumatoid arthritis, dyslipidemia and mild cognitive impairment. Franklin Lakes, NJ: Becton, Dickinson and Company; 2016.